Fundz

Megalabs Acquires Majority Interest and Control of DS Laboratories to enhance position in the global dermatology market

PRIVATEMay 31, 2024

Acquiring Company

Megalabs

Acquired Company

DS Laboratories

MiamiManufacturingBiotechnologyHealth CarePharmaceuticalHealth CareFashionBeautyLifestyle

Description

Megalabs, a leading pharmaceutical company, has acquired majority interest and control of DS Laboratories, a leading dermatology company focused on science-backed hair care across 50+ countries. This strategic move enhances Megalabs' position in the global dermatology market and the US.

Quick answer

Megalabs is acquiring DS Laboratories, announced May 31, 2024.

How much did Megalabs pay for DS Laboratories?
The deal value was not disclosed.
What does Megalabs do?
Megalabs is a leading pharmaceutical company committed to providing healthcare professionals and consumers with affordable therapeutic solutions for a healthier and more fulfilling life.
Where are Megalabs and DS Laboratories based?
DS Laboratories is based in Miami, Florida, United States.
Who are the decision-makers at Megalabs?
Fundz holds 1 contact at Megalabs. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Pharmaceutical and Fashion

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at Megalabs, and when

When Megalabs changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day Megalabs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Megalabs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Megalabs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Megalabs

About

Megalabs is a leading pharmaceutical company committed to providing healthcare professionals and consumers with affordable therapeutic solutions for a healthier and more fulfilling life. The company is present in 20 countries with more than 8,500 collaborators and offers more than 1,800 products that cross all therapeutic areas. Its continuous growth is supported by 18 production plants, a highly diversified portfolio with more than 1,800 products, and seven R&D centers. Megalabs is a forward-looking company with an established reputation as one of the leading pharmaceutical players in the Americas.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Megalabs makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Gianclaudio
Likely contact at this company
••••••••@••••••••

See Gianclaudio's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Megalabs's next move

Learn about Strategic plan

Frequently asked

Who acquired DS Laboratories?

DS Laboratories was acquired by Megalabs. The deal was reported on May 31, 2024. Megalabs is a leading pharmaceutical company committed to providing healthcare professionals and consumers with affordable therapeutic solutions for a healthier and more fulfilling life. Megalabs is privately held and operates in Manufacturing.

When did Megalabs acquire DS Laboratories?

Megalabs's acquisition of DS Laboratories was reported on May 31, 2024. Megalabs, a leading pharmaceutical company, has acquired majority interest and control of DS Laboratories, a leading dermatology company focused on science-backed hair care across 50+ countries. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does DS Laboratories do?

DS Laboratories is a pioneering dermatology company known for its advanced hair care products, operating in over 50+ countries. It markets through online channels, specialty retailers, distributors, and pharmacies. It is privately held, operating in Health Care, and is based in Miami.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.